AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals
TOKYO, March 4, 2019 /PRNewswire/ — AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain’s synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC). The transaction had been previously…
View more at https://www.prnewswire.com:443/news-releases/agc-completes-acquisition-of-spanish-synthetic-pharmaceutical-active-ingredient-manufacturer-malgrat-pharma-chemicals-300805594.html
Comments Off on AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals